{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-297177","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2025-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.687486+00:00","generated_at":"2026-05-16T16:53:58.866922+00:00","sec_items":["1.03","3.01","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"confidence":"high","headline":"Clearside Biomedical files for Chapter 11 bankruptcy; Nasdaq delisting effective Dec 1","bullets":["Filed voluntary Chapter 11 petition on Nov 23, 2025 in Delaware (Case No. 25-12109).","Nasdaq delisting notice received; trading suspended Dec 1, moving to OTC under symbol CLSDQ.","Company intends to sell substantially all assets through a Section 363 auction.","First-day motions filed to continue normal operations during the bankruptcy process.","Assets include SCS Microinjector platform, CLS-AX program, and multiple licensing deals."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-297177","json":"https://secwatch.observer/filing/0001193125-25-297177.json","markdown":"https://secwatch.observer/filing/0001193125-25-297177.md","text":"https://secwatch.observer/filing/0001193125-25-297177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/0001193125-25-297177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/d41251d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:53:58.866922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}